Non-infectious inflammatory diseases of the canine central nervous system (CNS) are common idiopathic disorders grouped under the term meningoencephalomyelitis of unknown origin (MUO). Ante mortem diagnosis is achieved via assessment of clinical signs, magnetic resonance imaging (MRI), and cerebrospinal fluid (CSF) analysis, but the definitive diagnosis needs histopathological examination. MUO are mostly considered as autoimmune CNS disorders, so that suppressing the immune reaction is the best management method for patients. Mesenchymal stem cells (MSCs) are under investigation to treat autoimmune and degenerative disorders due to their immunomodulatory and regenerative properties. This study aims to verify the safety, feasibility, and efficacy of MSCs treatment in canine idiopathic autoimmune inflammatory disorders of the CNS.
|Autori:||Zeira, Offer; Asiag, Nimrod; Aralla, Marina; Ghezzi, Erica; Pettinari, Letizia; Martinelli, Laura; Zahirpour, Daniele; Dumas, Maria Pia; Lupi, Davide; Scaccia, Simone; Konar, Martin; Cantile, Carlo|
|Titolo:||Adult autologous mesenchymal stem cells for the treatment of suspected non-infectious inflammatory diseases of the canine central nervous system: safety, feasibility and preliminary clinical findings|
|Anno del prodotto:||2015|
|Digital Object Identifier (DOI):||10.1186/s12974-015-0402-9|
|Appare nelle tipologie:||1.1 Articolo in rivista|